Skip to content
Canada's trusted research peptide sourceFree shipping from $250 CADPurity-tested compoundsPay by Interac e-TransferCanadian owned & operatedFast, discreet shippingCOA-backed qualityCanada-onlyCanada's trusted research peptide sourceFree shipping from $250 CADPurity-tested compoundsPay by Interac e-TransferCanadian owned & operatedFast, discreet shippingCOA-backed qualityCanada-onlyCanada's trusted research peptide sourceFree shipping from $250 CADPurity-tested compoundsPay by Interac e-TransferCanadian owned & operatedFast, discreet shippingCOA-backed qualityCanada-onlyCanada's trusted research peptide sourceFree shipping from $250 CADPurity-tested compoundsPay by Interac e-TransferCanadian owned & operatedFast, discreet shippingCOA-backed qualityCanada-onlyCanada's trusted research peptide sourceFree shipping from $250 CADPurity-tested compoundsPay by Interac e-TransferCanadian owned & operatedFast, discreet shippingCOA-backed qualityCanada-onlyCanada's trusted research peptide sourceFree shipping from $250 CADPurity-tested compoundsPay by Interac e-TransferCanadian owned & operatedFast, discreet shippingCOA-backed qualityCanada-onlyCanada's trusted research peptide sourceFree shipping from $250 CADPurity-tested compoundsPay by Interac e-TransferCanadian owned & operatedFast, discreet shippingCOA-backed qualityCanada-onlyCanada's trusted research peptide sourceFree shipping from $250 CADPurity-tested compoundsPay by Interac e-TransferCanadian owned & operatedFast, discreet shippingCOA-backed qualityCanada-only

GHRH analogue · Research reagent

Tesamorelin

A hormone-signalling peptide studied in clinical trials involving adults with HIV-related abdominal fat accumulation. Researchers measured internal abdominal fat and growth-related markers.

$156.99 CAD

· $15.70 / mgIn stock

Sample 5026_0273 · 100.00% purity

PPB Analytical Inc. · View report

Strength
Pack

In stock · Ships next business day from Toronto

Interac e-Transfer

$9.99 shipping, free from $250 · Ships from Toronto · Canada only

Shipping and returns: Ships next business day from Toronto · $9.99 shipping, free from $250 · Arrives right or we make it right

For research use only. Not for human consumption.

Independent lab report

Purity
100.00%
Laboratory
PPB Analytical Inc.
Report date
Mar. 27, 2026
Report ID
2026030634-02

Proof Line vials are filled from Align Biosciences stock under the Proof Line label. This is Align’s independent lab report for Tesamorelin 10 mg. The report records a laboratory sample ID; a production lot number is shown when the report includes one.

Purity
99.67%
Laboratory
Testides
Report date
May 18, 2026
Report ID
BW-TESA-10mg-050926-01
Supplier lot
VTL-TES10102
Measured content / label
9.37 mg / 10 mg

Proof Line vials are filled from Align Biosciences stock under the Proof Line label. This is Align’s independent lab report for Tesamorelin 10 mg. The report records a laboratory sample ID; a production lot number is shown when the report includes one.

About Tesamorelin

Tesamorelin, also published as TH9507, is catalogued here as: GHRH analogue, growth-axis research. Studied in adults with HIV-associated abdominal fat accumulation for imaging-measured visceral fat and hormone changes. Tesamorelin is described as an analogue of growth hormone-releasing hormone (GHRH), also called growth hormone-releasing factor (GRF). It prompts the body’s own growth-hormone signalling rather than being administered growth hormone, which is why IGF-I is measured as part of the studied response. A hormone-signalling peptide studied in clinical trials involving adults with HIV-related abdominal fat accumulation. Researchers measured internal abdominal fat and growth-related markers.

The relevant clinical research measured visceral adipose tissue by imaging in a defined patient population, alongside hormone markers, withdrawals and adverse events over a fixed study period.

A 2007 randomized trial in 412 patients with HIV and abdominal fat accumulation, over 26 weeks, reported reduced visceral fat and increased IGF-I in that population, with more withdrawals due to adverse events.

Human trial literature: A 26-week randomized trial in 412 patients reported reduced visceral fat and increased IGF-I. A specific fat compartment and patient population, not general weight loss or performance evidence.

Human trial literature: Withdrawals due to adverse events were more frequent in the treatment group. The trial medicine was not PLP’s vial or pen formulation.

Proof Line Peptides lists Tesamorelin as a vial in 10 mg and 5 mg, with pack sizes of 1, 3, 5 and 10. Prices are shown in Canadian dollars, and orders ship from Toronto by tracked Canadian service.

The matched PPB Analytical Inc. report for Tesamorelin 10 mg (report 2026030634-02, dated Mar. 27, 2026) records 100.00% purity. It documents the supplier sample sent for testing, not every shipped lot, and the original PDF is linked on this page.

Shipped lyophilized (freeze-dried) and stable at room temperature in transit. Store sealed vials in the fridge or freezer on arrival. Once reconstituted, refrigerate. Anything not right? Our guarantee covers it.

Often studied alongside